Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)

類似資料

• Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors
  著者:: Cure, Erkan, 等
  出版事項: (2021)
• Colchicine may not be effective in COVID-19 infection; it may even be harmful?
  著者:: Cumhur Cure, Medine, 等
  出版事項: (2020)
• Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?”
  著者:: Cure, Erkan, 等
  出版事項: (2020)
• Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis
  著者:: Kucuk, Adem, 等
  出版事項: (2020)
• NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection
  著者:: Cumhur Cure, Medine, 等
  出版事項: (2020)